Insider Trading & Ownership of Helen M. Boudreau

Location
Charlotte, NC
Summary
The estimated net worth of Helen M. Boudreau is at least $142,190 dollars as of 26 Nov 2025. Helen M. Boudreau is the Director of Cara Therapeutics, Inc. and owns shares of Tvardi Therapeutics, Inc. (TVRD) stock worth about $113K. Helen M. Boudreau is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
Signature
/s/ David L. Klatsky, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Helen M. Boudreau and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Helen M. Boudreau has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $142,190.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Cara Therapeutics, Inc. ($112,985).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Helen M. Boudreau

RLYB Forms 3/4/5

Rallybio Corp

Relationship
Director
Holdings value
$29,205
Past year net change
Change %
Report period
13 May 2025
PINC Forms 3/4/5

Premier, Inc.

Relationship
Director
Holdings value
$0
Past year net change
-$45,760
Change %
-100%
Report period
25 Nov 2025

Insider Transactions Reported by Helen M. Boudreau:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .